The global myasthenia gravis treatment market size stood at USD 1.15 billion in 2020. The market is projected to grow from USD 1.22 billion in 2021 to USD 2.03 billion in 2028, grow at a CAGR of 7.5% during the 2021-2028 period. The global impact of COVID-19 has been unprecedented and staggering, with myasthenia gravis treatment witnessing a negative impact across all regions amid the pandemic. Based on our analysis, the global market exhibited a slower growth of 4.6% in 2020 than the average year-on-year growth during 2017-2019.

For More Detailed Information: https://www.fortunebusinessins....ights.com/myasthenia